W. Voelker, M. Mauser, M. Preisack
Aug 1, 1989
Citations
0
Influential Citations
2
Citations
Journal
The American journal of cardiology
Abstract
Abstract Phosphodiesterase inhibitors show promise in the treatment of patients with severe congestive heart failure (CHF). 1,2 Adibendan is a new, orally active benzimidazole derivative, which exhibits phosphodiesterase inhibition and sensitivation of the myofilaments to calcium. 3